Alphabet Inc.

Q3 2025 13F-HR Detailed Holdings

Location
Mountain View, CA
Holdings as of
9/30/2025
Date filed
11/7/2025
Form type
13F-HR
Num holdings
40
Total value ($000)
$2,408,575
Net value change ($000)
+273,345 (12.8%)
New positions
2
Sold out positions
1
Turnover %
7.5%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 8/1/2025 Next filing: 2/13/2026 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
PL 219,765 112.8%
Metsera, Inc. 56,830 40.3%
PRME 54,552 146.6%
RVMD 40,961 26.9%
MAZE 32,954 111.3%
BBOT 32,692 NEW
TEM 26,632 27.0%
ASTS 21,017 5.0%
FIG 11,182 NEW
DNTH 4,324 111.2%
Top Reduces (Value $000, Stocks/ETFs)
Verve Therapeutics, Inc. -136,652 -100.0%
FRSH -50,889 -21.1%
ARM -39,706 -12.5%
DXCM -20,739 -22.9%
OSCR -1,210 -11.7%
SPRO -908 -35.2%
AUTL -454 -28.5%
GTLB -82 -0.1%
GUTS -19 -1.8%
QNCX -4 -1.3%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 GV Management Company, L.L.C. 028-22704
2 Google LLC 028-22705
3 CapitalG II LP 028-22706
4 Verily Life Sciences LLC 028-22703
5 CapitalG III LP 028-23659